Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 17400322)

1.

The natural history of hepatitis C with severe hepatic fibrosis.

Lawson A, Hagan S, Rye K, Taguri N, Ratib S, Zaitoun AM, Neal KR, Ryder SD, Irving WL; Trent HCV Study Group.

J Hepatol. 2007 Jul;47(1):37-45. Epub 2007 Mar 7.

PMID:
17400322
2.

[Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis].

Park JI, Choi KM, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Chung YH, Lee YS, Suh DJ.

Korean J Hepatol. 2007 Dec;13(4):543-55. Korean.

3.

Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.

Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, Borzio M, Redaelli A, Chiesa A, Silini EM, Almasio PL, Maisonneuve P.

Am J Gastroenterol. 2009 May;104(5):1147-58. doi: 10.1038/ajg.2009.31. Epub 2009 Apr 7.

PMID:
19352340
4.

Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.

Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.

Liver Transpl. 2003 Mar;9(3):228-35.

5.

The natural history of hepatitis C cirrhosis after liver transplantation.

Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.

Liver Transpl. 2009 Sep;15(9):1063-71. doi: 10.1002/lt.21784.

6.

Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.

Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D.

Liver Transpl. 2008 Dec;14(12):1766-77. doi: 10.1002/lt.21635.

7.

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J.

Hepatology. 2003 Aug;38(2):420-7.

PMID:
12883486
8.

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.

Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM.

J Viral Hepat. 2009 Jul;16(7):492-9. doi: 10.1111/j.1365-2893.2009.01098.x. Epub 2009 Feb 5.

PMID:
19200134
9.

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.

Ann Intern Med. 2007 Nov 20;147(10):677-84.

PMID:
18025443
10.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

11.

Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.

Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, Mela M, Manousou P, Senzolo M, Dhillon AP, Patch D, Burroughs AK.

Liver Transpl. 2007 Sep;13(9):1305-11.

12.

Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient.

Kalambokis G, Manousou P, Samonakis D, Grillo F, Dhillon AP, Patch D, O'Beirne J, Rolles K, Burroughs AK.

Transpl Int. 2009 Feb;22(2):172-81. doi: 10.1111/j.1432-2277.2008.00744.x. Epub 2008 Sep 10.

PMID:
18786149
14.

Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.

Planas R, Ballesté B, Alvarez MA, Rivera M, Montoliu S, Galeras JA, Santos J, Coll S, Morillas RM, Solà R.

J Hepatol. 2004 May;40(5):823-30.

PMID:
15094231
15.

Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.

Rigamonti C, Donato MF, Fraquelli M, Agnelli F, Ronchi G, Casazza G, Rossi G, Colombo M.

Gut. 2008 Jun;57(6):821-7. doi: 10.1136/gut.2007.135046. Epub 2008 Jan 24.

PMID:
18218676
16.

Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.

Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA.

Liver Transpl. 2008 Oct;14(10):1491-7. doi: 10.1002/lt.21548.

17.

Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.

Kim SU, Han KH, Nam CM, Park JY, Kim do Y, Chon CY, Ahn SH.

J Gastroenterol Hepatol. 2008 Nov;23(11):1722-7. doi: 10.1111/j.1440-1746.2008.05510.x. Epub 2008 Aug 20.

PMID:
18717757
18.

Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.

Calvaruso V, Dhillon AP, Tsochatzis E, Manousou P, Grillo F, Germani G, Patch D, O'Beirne J, Burroughs AK.

J Gastroenterol Hepatol. 2012 Jul;27(7):1227-32. doi: 10.1111/j.1440-1746.2012.07136.x.

PMID:
22432427
19.

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.

Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.

PMID:
19032460
20.

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P.

Gastroenterology. 2008 Sep;135(3):821-9. doi: 10.1053/j.gastro.2008.05.044. Epub 2008 May 21.

PMID:
18593587
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk